iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Shares Up 0.6% – Here’s What Happened

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)’s share price traded up 0.6% during trading on Thursday . The company traded as high as $22.99 and last traded at $22.96. 38,357 shares changed hands during mid-day trading, an increase of 15% from the average session volume of 33,216 shares. The stock had previously closed at $22.83.

iShares Genomics Immunology and Healthcare ETF Stock Down 0.6 %

The stock has a market cap of $133.56 million, a P/E ratio of 2.29 and a beta of 1.14. The company has a 50-day simple moving average of $23.94 and a two-hundred day simple moving average of $24.14.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

A hedge fund recently bought a new stake in iShares Genomics Immunology and Healthcare ETF stock. Avior Wealth Management LLC acquired a new position in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) during the third quarter, according to its most recent filing with the SEC. The firm acquired 9,500 shares of the company’s stock, valued at approximately $234,000. Avior Wealth Management LLC owned about 0.16% of iShares Genomics Immunology and Healthcare ETF as of its most recent filing with the SEC.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.